Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.45% |
| 2 | Technology | 16.09% |
| 3 | Consumer Staples | 10.57% |
| 4 | Consumer Discretionary | 9.95% |
| 5 | Communication Services | 9.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
RadNet
RDNT
$6.08B
| $24.9M | 0.02% |
1,568,070
-248,400
| -14% | -$3.6M |
|
702
Sanmina
SANM
$11.1B
| $24.8M | 0.02% |
991,441
+50,333
| +5% | +$1.32M |
|
703
NXP Semiconductors
NXPI
$58.5B
| $24.8M | 0.02% |
217,488
-140,100
| -39% | -$14M |
|
|
CATM
704
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $24.8M | 0.02% |
1,034,010
-402,300
| -28% | -$9.01M |
|
705
Manhattan Associates
MANH
$11.7B
| $24.8M | 0.02% |
262,880
-343,800
| -57% | -$25.6M |
|
706
CarParts.com
PRTS
$50.3M
| $24.7M | 0.02% |
285,586
+116,430
| +69% | +$6.2M |
|
|
FBC
707
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $24.6M | 0.02% |
836,361
-255,200
| -23% | -$6.54M |
|
708
Phibro Animal Health
PAHC
$1.38B
| $24.6M | 0.02% |
935,000
+61,200
| +7% | +$1.52M |
|
709
Zillow
ZG
$8.15B
| $24.6M | 0.02% |
+427,300
| New | +$21.1M |
|
|
MOBL
710
DELISTED
MobileIron, Inc.
MOBL
| $24.4M | 0.02% |
4,957,377
+617,539
| +14% | +$2.83M |
|
711
Pricesmart
PSMT
$5.55B
| $24.4M | 0.02% |
403,800
-21,200
| -5% | -$1.22M |
|
|
BRSL
712
Brightstar Lottery PLC
BRSL
$2.15B
| $24.3M | 0.02% |
2,729,112
+547,200
| +25% | +$4.27M |
|
|
CLCT
713
DELISTED
Collectors Universe
CLCT
| $24.2M | 0.02% |
706,038
-99,800
| -12% | -$2.27M |
|
714
Toronto Dominion Bank
TD
$203B
| $24.1M | 0.02% |
541,194
+386,275
| +249% | +$16.4M |
|
|
PDLI
715
DELISTED
PDL BioPharma, Inc.
PDLI
| $24.1M | 0.02% |
8,294,249
+70,718
| +0.9% | +$224K |
|
716
Tucows
TCX
$134M
| $24.1M | 0.02% |
420,751
+12,500
| +3% | +$694K |
|
717
Sun Communities
SUI
$14.6B
| $24.1M | 0.02% |
177,294
-352,556
| -67% | -$46.8M |
|
718
Empire State Realty Trust
ESRT
$836M
| $24M | 0.02% |
3,426,792
-1,235,900
| -27% | -$9.54M |
|
719
Akamai
AKAM
$18B
| $24M | 0.02% |
223,800
+35,606
| +19% | +$3.58M |
|
|
BLD
720
DELISTED
TopBuild
BLD
| $23.9M | 0.02% |
210,300
+69,200
| +49% | +$6.91M |
|
|
IBA
721
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $23.9M | 0.02% |
679,945
+31,000
| +5% | +$1.07M |
|
722
Williams-Sonoma
WSM
$28.5B
| $23.9M | 0.02% |
582,800
-446,108
| -43% | -$15.2M |
|
723
Royal Bank of Canada
RY
$299B
| $23.8M | 0.02% |
350,600
+222,813
| +174% | +$14.2M |
|
724
Employers Holdings
EIG
$871M
| $23.7M | 0.02% |
786,743
+242,200
| +44% | +$7.45M |
|
725
Watsco Inc
WSO
$12.9B
| $23.7M | 0.02% |
133,142
+39,900
| +43% | +$6.6M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 25% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.